Tree Nut Allergy
9
3
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.1%
1 terminated out of 9 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
The NACHO Trial (Nut Allergy Children OIT)
Peanut and Tree Nut Desensitization
TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation
Thresholds In Food Allergy evaluaTion And predictioN
Re-Introducing Nuts in Allergic Patients
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
Walnut Oral Immunotherapy for Tree Nut Allergy
Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy
Phenotypical Characterization of Peanut Allergic Children